Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 121 to 126 of 126 entries
Sorted by: Best Match Show Resources per page
Clinical relevance of topical antibiotic use in co-selecting for multidrug-resistant .

Antimicrobial agents and chemotherapy

Nong Y, Taiaroa G, Pasricha S, Guérillot R, Monk IR, Baines SL, Carter GP, Howden BP, Williamson DA.
PMID: 33593834
Antimicrob Agents Chemother. 2021 Feb 16; doi: 10.1128/AAC.02048-20. Epub 2021 Feb 16.

Topical antibiotic preparations, such as fusidic acid (FA) or mupirocin, are used in the prevention and treatment of superficial skin infections caused by staphylococci. Previous genomic epidemiology work has suggested an association between the widespread use of topical antibiotics...

Cite
Nong Y, Taiaroa G, Pasricha S, et al. Clinical relevance of topical antibiotic use in co-selecting for multidrug-resistant . Antimicrob Agents Chemother. 2021;doi: 10.1128/AAC.02048-20.
Nong, Y., Taiaroa, G., Pasricha, S., Guérillot, R., Monk, I. R., Baines, S. L., Carter, G. P., Howden, B. P., & Williamson, D. A. (2021). Clinical relevance of topical antibiotic use in co-selecting for multidrug-resistant . Antimicrobial agents and chemotherapy, . https://doi.org/10.1128/AAC.02048-20
Nong, Yi, et al. "Clinical relevance of topical antibiotic use in co-selecting for multidrug-resistant ." Antimicrobial agents and chemotherapy vol. (2021). doi: https://doi.org/10.1128/AAC.02048-20
Nong Y, Taiaroa G, Pasricha S, Guérillot R, Monk IR, Baines SL, Carter GP, Howden BP, Williamson DA. Clinical relevance of topical antibiotic use in co-selecting for multidrug-resistant . Antimicrob Agents Chemother. 2021 Feb 16; doi: 10.1128/AAC.02048-20. Epub 2021 Feb 16. PMID: 33593834; PMCID: PMC8092865.
Copy Download .nbib Format: NLM
Investigation of In-Vitro Adaptation toward Sodium Bituminosulfonate in .

Microorganisms

Blisse M, Idelevich EA, Becker K.
PMID: 33322073
Microorganisms. 2020 Dec 10;8(12). doi: 10.3390/microorganisms8121962.

The global increase in antimicrobial resistance has revived the interest in "old" substances with antimicrobial activity such as sodium bituminosulfonate. However, for those "old" compounds, scientific studies are still sparse and the ones available do not mostly meet the...

Cite
Blisse M, Idelevich EA, Becker K. Investigation of In-Vitro Adaptation toward Sodium Bituminosulfonate in . Microorganisms. 2020;8(12)doi: 10.3390/microorganisms8121962.
Blisse, M., Idelevich, E. A., & Becker, K. (2020). Investigation of In-Vitro Adaptation toward Sodium Bituminosulfonate in . Microorganisms, 8(12), . https://doi.org/10.3390/microorganisms8121962
Blisse, Marko, et al. "Investigation of In-Vitro Adaptation toward Sodium Bituminosulfonate in ." Microorganisms vol. 8,12 (2020). doi: https://doi.org/10.3390/microorganisms8121962
Blisse M, Idelevich EA, Becker K. Investigation of In-Vitro Adaptation toward Sodium Bituminosulfonate in . Microorganisms. 2020 Dec 10;8(12). doi: 10.3390/microorganisms8121962. PMID: 33322073; PMCID: PMC7763802.
Copy Download .nbib Format: NLM
Bioactivities and Structure-Activity Relationships of Fusidic Acid Derivatives: A Review.

Frontiers in pharmacology

Long J, Ji W, Zhang D, Zhu Y, Bi Y.
PMID: 34721042
Front Pharmacol. 2021 Oct 15;12:759220. doi: 10.3389/fphar.2021.759220. eCollection 2021.

Fusidic acid (FA) is a natural tetracyclic triterpene isolated from fungi, which is clinically used for systemic and local

Cite
Long J, Ji W, Zhang D, et al. Bioactivities and Structure-Activity Relationships of Fusidic Acid Derivatives: A Review. Front Pharmacol. 2021;12:759220doi: 10.3389/fphar.2021.759220.
Long, J., Ji, W., Zhang, D., Zhu, Y., & Bi, Y. (2021). Bioactivities and Structure-Activity Relationships of Fusidic Acid Derivatives: A Review. Frontiers in pharmacology, 12759220. https://doi.org/10.3389/fphar.2021.759220
Long, Junjun, et al. "Bioactivities and Structure-Activity Relationships of Fusidic Acid Derivatives: A Review." Frontiers in pharmacology vol. 12 (2021): 759220. doi: https://doi.org/10.3389/fphar.2021.759220
Long J, Ji W, Zhang D, Zhu Y, Bi Y. Bioactivities and Structure-Activity Relationships of Fusidic Acid Derivatives: A Review. Front Pharmacol. 2021 Oct 15;12:759220. doi: 10.3389/fphar.2021.759220. eCollection 2021. PMID: 34721042; PMCID: PMC8554340.
Copy Download .nbib Format: NLM
The Prevalence and Determinants of Fusidic Acid Resistance Among Methicillin-Resistant .

Frontiers in medicine

Zhao H, Wang X, Wang B, Xu Y, Rao L, Wan B, Guo Y, Wu X, Yu J, Chen L, Li M, Yu F.
PMID: 34917634
Front Med (Lausanne). 2021 Nov 30;8:761894. doi: 10.3389/fmed.2021.761894. eCollection 2021.

The significant increase in resistance of methicillin-resistant

Cite
Zhao H, Wang X, Wang B, et al. The Prevalence and Determinants of Fusidic Acid Resistance Among Methicillin-Resistant . Front Med (Lausanne). 2021;8:761894doi: 10.3389/fmed.2021.761894.
Zhao, H., Wang, X., Wang, B., Xu, Y., Rao, L., Wan, B., Guo, Y., Wu, X., Yu, J., Chen, L., Li, M., & Yu, F. (2021). The Prevalence and Determinants of Fusidic Acid Resistance Among Methicillin-Resistant . Frontiers in medicine, 8761894. https://doi.org/10.3389/fmed.2021.761894
Zhao, Huilin, et al. "The Prevalence and Determinants of Fusidic Acid Resistance Among Methicillin-Resistant ." Frontiers in medicine vol. 8 (2021): 761894. doi: https://doi.org/10.3389/fmed.2021.761894
Zhao H, Wang X, Wang B, Xu Y, Rao L, Wan B, Guo Y, Wu X, Yu J, Chen L, Li M, Yu F. The Prevalence and Determinants of Fusidic Acid Resistance Among Methicillin-Resistant . Front Med (Lausanne). 2021 Nov 30;8:761894. doi: 10.3389/fmed.2021.761894. eCollection 2021. PMID: 34917634; PMCID: PMC8669822.
Copy Download .nbib Format: NLM
The Prevalence and Determinants of Fusidic Acid Resistance Among Methicillin-Resistant .

Frontiers in medicine

Zhao H, Wang X, Wang B, Xu Y, Rao L, Wan B, Guo Y, Wu X, Yu J, Chen L, Li M, Yu F.
PMID: 34917634
Front Med (Lausanne). 2021 Nov 30;8:761894. doi: 10.3389/fmed.2021.761894. eCollection 2021.

The significant increase in resistance of methicillin-resistant

Cite
Zhao H, Wang X, Wang B, et al. The Prevalence and Determinants of Fusidic Acid Resistance Among Methicillin-Resistant . Front Med (Lausanne). 2021;8:761894doi: 10.3389/fmed.2021.761894.
Zhao, H., Wang, X., Wang, B., Xu, Y., Rao, L., Wan, B., Guo, Y., Wu, X., Yu, J., Chen, L., Li, M., & Yu, F. (2021). The Prevalence and Determinants of Fusidic Acid Resistance Among Methicillin-Resistant . Frontiers in medicine, 8761894. https://doi.org/10.3389/fmed.2021.761894
Zhao, Huilin, et al. "The Prevalence and Determinants of Fusidic Acid Resistance Among Methicillin-Resistant ." Frontiers in medicine vol. 8 (2021): 761894. doi: https://doi.org/10.3389/fmed.2021.761894
Zhao H, Wang X, Wang B, Xu Y, Rao L, Wan B, Guo Y, Wu X, Yu J, Chen L, Li M, Yu F. The Prevalence and Determinants of Fusidic Acid Resistance Among Methicillin-Resistant . Front Med (Lausanne). 2021 Nov 30;8:761894. doi: 10.3389/fmed.2021.761894. eCollection 2021. PMID: 34917634; PMCID: PMC8669822.
Copy Download .nbib Format: NLM
Topical retapamulin in the management of infected traumatic skin lesions.

Therapeutics and clinical risk management

Shawar R, Scangarella-Oman N, Dalessandro M, Breton J, Twynholm M, Li G, Garges H.
PMID: 19436611
Ther Clin Risk Manag. 2009 Feb;5(1):41-9. doi: 10.2147/tcrm.s3459. Epub 2009 Mar 26.

Retapamulin is a novel semisynthetic pleuromutilin antibiotic specifically designed for use as a topical agent. The unique mode of action by which retapamulin selectively inhibits bacterial protein synthesis differentiates it from other nonpleuromutilin antibacterial agents that target the ribosome...

Cite
Shawar R, Scangarella-Oman N, Dalessandro M, et al. Topical retapamulin in the management of infected traumatic skin lesions. Ther Clin Risk Manag. 2009;5(1):41-9doi: 10.2147/tcrm.s3459.
Shawar, R., Scangarella-Oman, N., Dalessandro, M., Breton, J., Twynholm, M., Li, G., & Garges, H. (2009). Topical retapamulin in the management of infected traumatic skin lesions. Therapeutics and clinical risk management, 5(1), 41-9. https://doi.org/10.2147/tcrm.s3459
Shawar, Ribhi, et al. "Topical retapamulin in the management of infected traumatic skin lesions." Therapeutics and clinical risk management vol. 5,1 (2009): 41-9. doi: https://doi.org/10.2147/tcrm.s3459
Shawar R, Scangarella-Oman N, Dalessandro M, Breton J, Twynholm M, Li G, Garges H. Topical retapamulin in the management of infected traumatic skin lesions. Ther Clin Risk Manag. 2009 Feb;5(1):41-9. doi: 10.2147/tcrm.s3459. Epub 2009 Mar 26. PMID: 19436611; PMCID: PMC2697516.
Copy Download .nbib Format: NLM
Showing 121 to 126 of 126 entries